| 21/39 | US=69 / Câncer Craft BS, Moulder S. Targeted therapy in breast cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 43-59. ISBN 978-1-60327-423-4. TERAPIA-ALVO NO CANCRO DA MAMA; CANCER DE MAMA; TERAPIA BIOLOGICA; TERAPIA-ALVO; TERAPIA ADJUVANTE; DOENCA METASTATICA |
| 22/39 | US=69 / Câncer Kopetz S. Targeted therapy in colorectal cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 101-23. ISBN 978-1-60327-423-4. TERAPIA-ALVO; CANCER COLORRETAL; EGFR; VEGF; ANTICORPOS MONOCLONAIS |
| 23/39 | US=69 / Câncer Stewart DJ. Targeted therapy in non-small cell lung cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 125-56. ISBN 978-1-60327-423-4. TERAPIA-ALVO; NAO-PEQUENAS DE CANCER DE PULMAO DE CELULAS; EGFR; ERLOTINIB; GEFITINIB; VEGFR |
| 24/39 | US=69 / Câncer Zhou Y, Alexanian R, Wang M. Targeted therapy in multiple myeloma. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 213-36. ISBN 978-1-60327-423-4. TERAPIA-ALVO; MIELOMA MULTIPLO; PATOGENESE MOLECULAR; MICROAMBIENTE |
| 25/39 | US=69 / Câncer Quintás-Cardama A, Kantarjian H, Garcia-Manero G, Cortes J. Targeted therapy in myelodysplastic syndrome. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 237-60. ISBN 978-1-60327-423-4. TERAPIA-ALVO; SINDROME MIELODISPLASICA; DECITABINA; A METILACAO DO DNA; 5-AZACITIDINA; LENALIDOMIDA |
| 26/39 | US=69 / Câncer Markman M. Targeted therapy in epithelial ovarian cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 261-9. ISBN 978-1-60327-423-4. TERAPIA-ALVO; CANCER EPITELIAL DE OVARIO; CANCRO DO OVARIO; CISPLATINA; CARBOPLATINA; AGENTES ANTI-ANGIOGENICOS; BEVACIZUMAB |
| 27/39 | US=69 / Câncer Gibbons DL, Wolff RA, Varadhachary G. Targeted drug therapy in pancreatic cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 271-87. ISBN 978-1-60327-423-4. TERAPIA MEDICAMENTOSA ALVO DE CANCER DE PANCREAS; TERAPIA-ALVO; CANCER DE PANCREAS; QUIMIOTERAPIA; ENSAIOS CLINICOS |
| 28/39 | US=69 / Câncer Zurita AJ, Ward JF, Kim J. Targeted therapy in prostate cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 289-304. ISBN 978-1-60327-423-4. TERAPIA-ALVO; CANCER DE PROSTATA; CANCER DE PROSTATA; NEOPLASIA DE PROSTATA; RESISTENTE A CASTRACAO CANCRO DA PROSTATA; ANDROGENO RECEPTOS; ANSAMICINAS; MTOR; ANGIOGENESE; IMUNOTERAPIA |
| 29/39 | US=69 / Câncer Jonasch E, Tannir N. Targeted therapy in renal cell carcinoma. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 305-16. ISBN 978-1-60327-423-4. TERAPIA-ALVO; CARCINOMA DE CELULAS RENAIS; MUTACAO BVS; ANTIVASCULAR TERAPIA; TERAPEUTICA DE COMBINACAO; TERAPIA SEQUENCIAL |
| 30/39 | US=69 / Câncer Hong D, Chintala L. Combining targeted therapies. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 361-81. ISBN 978-1-60327-423-4. COMBINANDO TERAPIAS-ALVO; TERAPIA-ALVO; TERAPIA PERSONALIZADA; VIAS DE SINALIZACAO; RESISTENCIA A DROGAS; DESENVOLVIMENTO DE DROGAS |
| 31/39 | US=69 / Câncer Camacho LH. Drug development in cancer medicine: challenges for targeted approaches. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 383-410. ISBN 978-1-60327-423-4. DESENVOLVIMENTO DE DROGAS EM CANCER; TERAPIA-ALVO; DESAFIOS; OBSTACULOS; DESENVOLVIMENTO DE DROGAS; ENSAIOS CLINICOS; FASE I |
| 32/39 | US=69 / Câncer Welsh SJ, Powis G. Toward personalized therapy for cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 411-25. ISBN 978-1-60327-423-4. TERAPIA PERSONALIZADA PARA O CANCER; CANCER; MEDICINA PERSONALIZADA; TERAPIA INDIVIDUALIZADA; FARMACOGENOMICA; TERAPIA-ALVO; ALVOS MOLECULARES |
| 33/39 | US=80 / Biol/Mol Alaoui-Jamali MA, Pinto D. Proteomic profiling of tyrosine kinases as pharmacological endpoints for targeted cancer therapy. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 59-77. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. TIROSINA-QUINASES PROTEICAS; CANCER; TERAPIA-ALVO; PROTEOMICA |
| 34/39 | US=84-A / Biol/Mol Micke P, Moustakas A, Ohshima M, Kappert K. Transformig growth factor-B in developing and advanced cancers: cancer-associated fibroblasts and the role of TGF-B. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 417-41. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. ASSOCIADAS CANCER FIBROBLASTOS; ESTROMA; ASSOCIADAS CANCER FIBROBLASTOS; TUMOR DO ESTROMA INTERACCAO; MIOFIBROBLASTOS; TERAPIA-ALVO; TGFB-1; MICROARRAY; EXPRESSAO DO GENE; CANCER |
| 35/39 | US=1 / Quimioterapia Esper P. Targeted therapy. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 57-75. ISBN 978-1-890504-68-7. TERAPIA-ALVO; TERAPIA DO CANCER; HISTORIA TERAPIAS-ALVO; EVOLUCAO DE TERAPIAS-ALVO; ALVO RECEPTORES DA SUPERFICIE CELULAR; PAPEL DO ENFERMEIRO DE ONCOLOGIA EM TERAPIA-ALVO; PACIENTE E EDUCACAO FAMILIAR |
| 36/39 | US=21 / Neurologia Vogelbaum M, Thomas T. Contemporary investigational treatments: small molecule agents. In: Barnett GH. High-grade gliomas: diagnosis and treatment. New Jersey: Humana Press, 2007. p. 337-56. (Current Clinical Oncology) ISBN 978-1-58829-511-8. GLIOMA DE ALTO GRAU. TERAPIA; AGENTES MOLECULARES; INIBIDORES DE GLIOMA; FATORES DE CRESCIMENTO; DROGAS DE MOLECULAS PEQUENAS; TERAPIA-ALVO; INIBIDORES DE QUINASE DE TIROSINA |
| 37/39 | US=46 / Câncer Reiter Y, Lev A. Immunotoxins and recombinant immunotoxins in cancer therapy. In: Meyers RA. Cancer: from mechanisms to therapeutic approaches. New Jersey: Wiley-Blackwell, 2007. p. 409-41. ISBN 978-3-527-31768-4. IMUNOTOXINAS; IMUNOTOXINAS RECOMBINANTES EM TERAPIA DO CANCER; TERAPIA DO CANCER; IMMUNOTOXINS; ANTICORPOS RECOMBINANTES; TERAPIA-ALVO |
| 38/39 | US=92 / Biol/Mol Deininger M. Established cancer therapies: tyrosine kinase inhibitors. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 477-508. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TERAPIA-ALVO; BCR-ABL; FLT3; EGFR; TYROSISE INIBITORS QUINASE; IMATINIB; GEFITINIB; ERLOTINIB; CANCER; LEUCEMIA |
| 39/39 | US=92 / Biol/Mol Furman RR, Leonard JP, Decter J, Coleman M. Recent and developing cancer therapies: monoclonal antibodies in lymphomas. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 511-36. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |